The global Narcolepsy Treatment Market size was estimated at USD 3.2 Bn in 2021, growing at a CAGR of 9.8% during the forecast period 2021-2027. Narcolepsy is a lifelong sleeping disorder which makes you feel immensely tired sometimes with uncontrollable sudden sleep attacks in severe cases. It is a disabling condition which is characterized by three different symptoms such as excessive daytime cataplexy, sleepiness and irresistible sleep episodes, fluctuating automatic behaviours. Narcolepsy generally begins between 15 to 25 years and it can be evident at any age. Global Narcolepsy Treatment Market is untreated and undiagnosed in many cases. Narcolepsy is the 3rd most common sleeping disorder which affects the large group of the population. A prevalence rate of narcolepsy is substantially lower in Israel i.e. 1 in 500,000 people and considerably high in Japan i.e. 1 in 600 in comparison with U.S. according to the narcolepsy network. Narcolepsy is not curable but can be treated with drugs like dextroamphetamine, methylphenidate etc. to reduce the sleep attacks. Mergers and acquisitions, collaborations, expansions to untapped geographies are the growth strategies that are adopted by the market players to enhance the market growth and to improve their product portfolio. Several voluntary organizations across the world such as Wake up Narcolepsy, Narcolepsy Network, American Sleep Association, and European Narcolepsy Network are actively involving in spreading the awareness regarding the sleeping disorders and their associated symptoms like EDS, sleep paralysis, and cataplexy.